|
Volumn 363, Issue 18, 2010, Pages 1763-
|
Products at risk
a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GLUCOCORTICOID;
PLACEBO;
SALMETEROL;
TIOTROPIUM BROMIDE;
BECLOMETASONE;
BRONCHODILATING AGENT;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
SALBUTAMOL;
SCOPOLAMINE DERIVATIVE;
ADULT;
ASTHMA;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
DRUG INDUSTRY;
DRUG MEGADOSE;
DRUG RESEARCH;
DRUG UTILIZATION;
EDITORIAL;
HUMAN;
PRIORITY JOURNAL;
ANALOGS AND DERIVATIVES;
COMPARATIVE EFFECTIVENESS;
CROSSOVER PROCEDURE;
DRUG COMBINATION;
INHALATIONAL DRUG ADMINISTRATION;
ADMINISTRATION, INHALATION;
ALBUTEROL;
ASTHMA;
BECLOMETHASONE;
BRONCHODILATOR AGENTS;
CHOLINERGIC ANTAGONISTS;
COMPARATIVE EFFECTIVENESS RESEARCH;
CROSS-OVER STUDIES;
DRUG INDUSTRY;
DRUG THERAPY, COMBINATION;
GLUCOCORTICOIDS;
HUMANS;
PLACEBOS;
SCOPOLAMINE DERIVATIVES;
|
EID: 78049438304
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMe1010348 Document Type: Editorial |
Times cited : (9)
|
References (1)
|